Feprazone Inhibitor

Feprazone is a pyrazolone anti-inflammatory agent. It is used for joint and muscular pain.

Berry DJ, Crome P, Corless D, Parke DV. The pharmacokinetics of single oral doses of feprazone in healthy volunteers and elderly patients. Xenobiotica. 1991 Sep;21(9):1211-6. PubMed PMID: 1788989.
Spahn H, Mutschler E. The influence of aluminium hydroxide on the bioavailability of feprazone. Single dose study. Arzneimittelforschung. 1985;35(1):167-9. PubMed PMID: 4039147.
Meloni T, Forteleoni G, Serra M, Daniotti S, Negri L, Giuntini P, Canepa L, Gaetani GF. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects. J Clin Pharmacol. 1982 Aug-Sep;22(8-9):418-20. PubMed PMID: 7130431.
Berry D, Parke DV. The disposition of feprazone and its hydroxylated metabolite in human volunteers. Xenobiotica. 1988 Jul;18(7):857-68. PubMed PMID: 3176523.

Small volumes of Feprazone, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5758608 is an inhibitor targeting Feprazone.